Efficient CAR-NK Cell Production from Stem Cells Boosts Cancer Immunotherapy Potential
A significant advancement in cancer immunotherapy has emerged from research in China, offering a potentially scalable and cost-effective method for producing natural killer (NK) cells – a crucial component of the body’s immune defense against cancer. Scientists have demonstrated the ability to generate up to 14 million tumor-killing NK cells from a single hematopoietic stem … Read more